Stay updated on Anti-IgE MAb in Allergic Asthma Clinical Trial

Sign up to get notified when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-IgE MAb in Allergic Asthma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:56.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 from v3.4.3. No changes to the study details or other content on the page.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Frontend updated from v3.4.2 to v3.4.3. No changes to study content or data are visible on the page.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:38.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-status notice and the prior Revision: v3.4.1 line were removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:22:18.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a 2026 publication: Lai K, et al. Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial. Allergy Asthma Immunol Res. 2026 Jan;18(1):39-54. Removed the earlier 2025 ahead-of-print citation and updated the page to Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:17:44.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added glossary display and new QC metadata (Last Update Submitted that Met QC Criteria) with revision v3.4.0; removed the older QC label (Last Update Submitted that met QC Criteria), the No FEAR Act data wording, and updated the revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:13:41.000Z thumbnail image

Stay in the know with updates to Anti-IgE MAb in Allergic Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.